Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. platinum

PLATINUM SIGNED

Portable Diagnostic Medical Device Based on Lab-on-Chip for Detection of Protein Biomarkers of Medical Interest.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 PLATINUM project word cloud

Explore the words cloud of the PLATINUM project. It provides you a very rough idea of what is the project "PLATINUM" about.

seal    prevention    equipped    loc    excellence    durable    diagnostic    vibrations    trl7    care    hba1c    temperatures    faster    biomarkers    lab    feasibility    consisting    phone    final    point    got    laboratory    stage    relies    storage    conceived    room    minutes    hospital    programmable    consists    assistance    microelectromechanical    innovative    protein    quantify    stable    smart    disposable    plan    prototyping    blood    solid    cheaper    assay    minimises    business    calibration    intends    regards    10    ambient    costlier    comprising    solutions    fluids    pharmacy    versatile    breakthrough    precise    hemoglobin    drop    molecule    biological    manipulation    alternatives    separation    glycated    qualified    foreseen    detection    2015    excellent    chip    temperature    diagnosis    option    device    ec    external    market    self    monitoring    medical    amount    validating    stored    wp    portable    diabetes    designed    labelling    detect    software    patient   

Project "PLATINUM" data sheet

The following table provides information about the project.

Coordinator		 DIANAX SRL 

Organization address
address: VIALE ORTLES 22/24
city: MILANO
postcode: 20139
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Italy [IT]
 Project website http://dianax.eu/horizon-2020/
 Total cost 3˙101˙625 €
 EC max contribution 2˙171˙137 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2016
 Duration (year-month-day) from 2016-08-01   to  2018-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DIANAX SRL IT (MILANO) coordinator 2˙171˙137.00

Map

 Project objective

The project aims at developing, prototyping, validating and bringing to market a portable assay system for the pre-diabetes and diabetes diagnosis and control, consisting of a disposable medical device equipped with a Lab-on-Chip (LoC) used for Point of Care or Self-Monitoring of protein biomarkers in biological fluids, like Glycated Hemoglobin (HbA1c). The medical device relies on a unique technology for diagnosis via protein biomarkers analysis, comprising a separation and a labelling stage of target molecule to detect and quantify the amount of glycated Hemoglobin in a drop of blood. The way this diagnostic medical device has been conceived and designed makes it unique compared to other devices available in the market. It is based on a disposable chip, easy to use, which does not require qualified personnel assistance and minimises manipulation. Stable at room temperature both in storage and during use, it does not need external calibration. These characteristics, together with its low cost, make it an excellent option for the final user (patient, pharmacy, hospital, etc.). The proposed diagnostic medical device consists of a LoC based on breakthrough microelectromechanical systems for protein detection through the protein biomarkers analysis. Such medical device is cheaper (€2-3/device), faster (~10 minutes), more robust (to vibrations, to high/low temperatures), more durable (2 years ambient-stored) and more versatile (easy to use, software-programmable, smart-phone integrated) than the already available and the foreseen portable alternatives, while being as precise as the costlier laboratory solutions. The project is relevant to the selected WP because it regards an innovative medical device for diabetes and pre-diabetes, thus with diagnostic and prevention applications, based on a solid feasibility study and a business plan. The project intends to bring the medical device from TRL7 to market. In addition, it already got the EC’s Seal of Excellence in 2015

 Deliverables

List of deliverables.
Implementation of a Web-platform Websites, patent fillings, videos etc. 2019-05-31 10:45:17
Kick-off meeting report and action planning Documents, reports 2019-05-31 10:45:09
Appointment of the PMT and SAB Documents, reports 2019-05-31 10:45:05
Preliminary costs analysis Documents, reports 2019-05-31 10:44:58

Take a look to the deliverables list in detail:  detailed list of PLATINUM deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PLATINUM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PLATINUM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

ClearRing (2018)

An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.

Read More  

JUMPAIR (2018)

Decubitus Ulcers Diseases Diagnoses by means of Smart ICT Anti-Decubitus System based on known Ulcers Activity Biomarkers

Read More